使用PharmCAT工具用于药物遗传学临床决策支持
Kevin Tippenhauer1, Marwin Philips1, Carlo Largiadèr2
1Bern University of Applied Sciences, Quellgasse 21, 2500 Biel, Switzerland.
通过将剂量指南与遗传数据进行映射,PharmCAT有助于制药遗传学临床决策支持. 该系统解决了将遗传变异整合到个性化医学的临床工作流程中的挑战.
科学领域:
- 药物遗传学 药物遗传学
- 临床信息学 临床信息学
- 基因组医学是基因组医学.
背景情况:
- 药物遗传学对于个性化医学至关重要,指导药物选择和基于遗传变异的剂量.
- 临床决策支持系统 (CDSS) 对于将复杂的遗传信息转化为可操作的临床实践至关重要.
- 将药物遗传数据集成到电子健康记录中,带来了重大的技术和后勤挑战.
研究的目的:
- 为在药物遗传学临床决策支持管道中利用PharmCAT提供见解.
- 为应对将临床剂量指南映射到遗传变异的挑战.
- 描述PharmCAT集成到临床信息系统中的方式.
主要方法:
- 药物遗传学原理的一般概述.
- 详细描述PharmCAT的特性和功能.
- 解释PharmCAT集成到临床信息系统中的过程.
主要成果:
- PharmCAT有效地弥合了遗传数据和临床剂量建议之间的差距.
- 综合系统简化了将药物遗传学见解应用于患者护理的过程.
- 证明了药物遗传学临床决策支持的可行管道.
结论:
- PharmCAT是药物遗传学临床决策支持的宝贵工具.
- 成功整合到临床信息系统是可行的和有益的.
- 未来的PharmCAT发布有望促进医疗保健中的药物遗传学实施.
更多相关视频
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
相关概念视频
Analysis of Population Pharmacokinetic Data
Drug Discovery: Overview
Biopharmaceutics and Pharmacokinetics: Overview
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
